Co-Authors
This is a "connection" page, showing publications co-authored by Bruno Lina and Maude Bouscambert-Duchamp.
Connection Strength
0.801
-
Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study. Sci Rep. 2021 07 22; 11(1):14977.
Score: 0.239
-
Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020. Euro Surveill. 2021 01; 26(3).
Score: 0.230
-
Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19. Lancet Microbe. 2021 Sep; 2(9):e424.
Score: 0.060
-
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
Score: 0.059
-
Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020. Clin Infect Dis. 2020 07 28; 71(15):825-832.
Score: 0.056
-
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del). Clin Microbiol Infect. 2020 07; 26(7):960-962.
Score: 0.055
-
Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 06; 20(6):697-706.
Score: 0.055
-
Genetic characterization of respiratory syncytial virus highlights a new BA genotype and emergence of the ON1 genotype in Lyon, France, between 2010 and 2014. J Clin Virol. 2018 05; 102:12-18.
Score: 0.047